Skip to main content

Table 2 Frequency of clinical respiratory symptoms at the time of follow-up

From: Pulmonary function in children post -SARS-CoV-2 infection: a systematic review and meta-analysis

Study name

Clinical respiratory symptoms after infection

Bogusławski (2023)

Persistent symptoms were presented in 17.1% of children. They included:

Decreased exercise tolerance (57.1%)

Dyspnea (42.9%)

Cough (42.9%)

Fatigue (28.6%)

Sleeping difficulties (14.3%)

Impaired concentration (14.3%)

Lack of appetite (14.3%)

Chiara (2022)

No symptom at rest

No exercise-induced respiratory symptoms

Ipek (2022)

Not presented in the article

Knoke (2022)

Any long-term complaints were reported in 27.1% of patients. They included:

Fatigue (14.28%)

Loss of smell/taste (10%)

Breathing problems (8.57%)

Headache (4.28%)

Cough (2.85%)

Ozturk (2022)

Respiratory symptoms were reported in 28% of patients. They included:

Dyspnea (35.7%)

Exertional dyspnea (35.7%)

Cough (21.4%)

Chest pain and tightness (21.4%)

Palacios (2022)

Respiratory symptoms were reported in 48.7% of patients. They included:

Shortness of breath during exercise (67.5%)

Chest pain (20%)

Dyspnea (15%)

Cough (12.5%)

Bottino (2021)

All patients were free of respiratory symptoms at the time of follow-up

Dobkin (2021)

Persistent dyspnea and/or exertional dyspnea (96.6%)

Cough (51.7%)

Exercise intolerance (48.3%)

Fatigue (13.8%)

One subject had an ongoing supplemental oxygen requirement